Sökning: WFRF:(Fey Martin F.) > Patterns of recurre...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02950naa a2200409 4500 | |
001 | oai:gup.ub.gu.se/99958 | |
003 | SwePub | |
008 | 240528s2009 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/999582 URI |
024 | 7 | a https://doi.org/10.1007/s10549-008-0282-02 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Pagani, Olivia4 aut |
245 | 1 0 | a Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. |
264 | c 2009-01-10 | |
264 | 1 | b Springer Science and Business Media LLC,c 2009 |
520 | a The current therapeutic strategy in breast cancer is to identify a target, such as estrogen receptor (ER) status, for tailoring treatments. We investigated the patterns of recurrence with respect to ER status for patients treated in two randomized trials with 25 years' median follow-up. In the ER-negative subpopulations most breast cancer events occurred within the first 5-7 years after randomization, while in the ER-positive subpopulations breast cancer events were spread through 10 years. In the ER-positive subpopulation, 1 year endocrine treatment alone significantly prolonged disease-free survival (DFS) with no additional benefit observed by adding 1 year of chemotherapy. In the small ER-negative subpopulation chemo-endocrine therapy had a significantly better DFS than endocrine alone or no treatment. Despite small numbers of patients, "old-fashioned" treatments, and competing causes of treatment failure, the value of ER status as a target for response to adjuvant treatment is evident through prolonged follow-up. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
700 | 1 | a Price, Karen N4 aut |
700 | 1 | a Gelber, Richard D4 aut |
700 | 1 | a Castiglione-Gertsch, Monica4 aut |
700 | 1 | a Holmberg, Stig B,d 1946u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery4 aut |
700 | 1 | a Lindtner, Jurij4 aut |
700 | 1 | a Thürlimann, Beat4 aut |
700 | 1 | a Collins, John4 aut |
700 | 1 | a Fey, Martin F4 aut |
700 | 1 | a Coates, Alan S4 aut |
700 | 1 | a Goldhirsch, Aron4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för kirurgi4 org |
773 | 0 | t Breast cancer research and treatmentd : Springer Science and Business Media LLCg 117:2, s. 319-24q 117:2<319-24x 1573-7217x 0167-6806 |
856 | 4 | u https://europepmc.org/articles/pmc3589101?pdf=render |
856 | 4 8 | u https://gup.ub.gu.se/publication/99958 |
856 | 4 8 | u https://doi.org/10.1007/s10549-008-0282-0 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy